A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET).
Cleland JG, Goode K, Erhardt L, Remme WJ, Charlesworth A, Poole-Wilson PA, Di Lenarda A, Hanrath P, Komajda M, Metra M, Swedberg K, Torp-Pedersen C; Carvedilol or Metoprolol European Trial Investigators.
Cleland JG, et al. Among authors: charlesworth a.
Cardiovasc Drugs Ther. 2004 Mar;18(2):139-52. doi: 10.1023/B:CARD.0000029032.46744.56.
Cardiovasc Drugs Ther. 2004.
PMID: 15162076
Clinical Trial.